[PDF][PDF] Type 2 immunity in tissue repair and fibrosis

RL Gieseck, MS Wilson, TA Wynn - Nature Reviews Immunology, 2018 - nature.com
Type 2 immunity is characterized by the production of IL-4, IL-5, IL-9 and IL-13, and this
immune response is commonly observed in tissues during allergic inflammation or infection …

Intracellular pathogens: host immunity and microbial persistence strategies

A Thakur, H Mikkelsen… - Journal of immunology …, 2019 - Wiley Online Library
Infectious diseases caused by pathogens including viruses, bacteria, fungi, and parasites
are ranked as the second leading cause of death worldwide by the World Health …

Risankizumab for ulcerative colitis: two randomized clinical trials

E Louis, S Schreiber, R Panaccione, P Bossuyt… - Jama, 2024 - jamanetwork.com
Importance The clinical effects of risankizumab (a monoclonal antibody that selectively
targets the p19 subunit of IL-23) for the treatment of ulcerative colitis are unknown. Objective …

Interleukin 17 is a chief orchestrator of immunity

M Veldhoen - Nature immunology, 2017 - nature.com
Increased understanding of the biology of interleukin 17 (IL-17) has revealed that this
cytokine is a central player in immunity at the sites most exposed to microorganisms …

IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases

MWL Teng, EP Bowman, JJ McElwee, MJ Smyth… - Nature medicine, 2015 - nature.com
Abstract The cytokine interleukin-12 (IL-12) was thought to have a central role in T cell–
mediated responses in inflammation for more than a decade after it was first identified …

Cytokines and Chemokines in Mycobacterium tuberculosis Infection

R Domingo-Gonzalez, O Prince, A Cooper… - Microbiology …, 2016 - journals.asm.org
Chemokines and cytokines are critical for initiating and coordinating the organized and
sequential recruitment and activation of cells into Mycobacterium tuberculosis-infected …

The immune response in tuberculosis

A O'Garra, PS Redford, FW McNab… - Annual review of …, 2013 - annualreviews.org
There are 9 million cases of active tuberculosis reported annually; however, an estimated
one-third of the world's population is infected with Mycobacterium tuberculosis and remains …

Th1 and Th17 cells in tuberculosis: protection, pathology, and biomarkers

IV Lyadova, AV Panteleev - Mediators of inflammation, 2015 - Wiley Online Library
The outcome of Mycobacterium tuberculosis (Mtb) infection ranges from a complete
pathogen clearance through asymptomatic latent infection (LTBI) to active tuberculosis (TB) …

T cells and adaptive immunity to Mycobacterium tuberculosis in humans

LD Jasenosky, TJ Scriba, WA Hanekom… - Immunological …, 2015 - Wiley Online Library
The adaptive immune response mediated by T cells is critical for control of Mycobacterium
tuberculosis (M. tuberculosis) infection in humans. However, the M. tuberculosis antigens …

Treatment of psoriasis patients with latent tuberculosis using IL-17 and IL-23 inhibitors: a retrospective, multinational, multicentre study

T Torres, A Chiricozzi, L Puig, AM Lé… - American Journal of …, 2024 - Springer
Background Tuberculosis has a major global impact. Immunocompetent hosts usually
control this disease, resulting in an asymptomatic latent tuberculosis infection (LTBI) …